Results 161 to 170 of about 1,663 (174)

INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA

Retina, 2016
Diabetic macular edema is the leading cause of blindness in young adults in developed countries. Beyond metabolic control, several therapies have been studied such as laser treatment and intravitreal injections of corticosteroids or anti-vascular endothelial growth factor drugs.
Gabriel Costa de, Andrade, João Rafael de Oliveira, Dias, André, Maia, Michel Eid, Farah, Carsten H, Meyer, Eduardo Büchele, Rodrigues   +5 more
openaire   +2 more sources

Long-term safety and efficacy of ziv-aflibercept in retinal diseases

British Journal of Ophthalmology, 2017
To investigate the long-term safety of intravitreal ziv-aflibercept in eyes receiving six or more intravitreal injections of ziv-aflibercept, an off-label substitute to the approved aflibercept.Consecutive patients with retinal disease receiving six or more of intravitreal 0.05 mL ziv-aflibercept (1.25 mg) injections were followed monthly in three ...
Ahmad M Mansour, Mohammed Ashraf, Chintan J Dedhia, Abdulrazzak Charbaji, Ahmed A R Souka, Jay Chhablani   +5 more
openaire   +2 more sources

Ziv-aflibercept

2021
openaire   +1 more source

Ziv‐aflibercept: A cost‐effective, off‐label, highly potent antagonist of vascular endothelial growth factor

Acta Ophthalmologica, 2020
Ahmad M Mansour, Michel Eid E Farah, Hana Mansour   +2 more
exaly  

Use of Ziv Aflibercept in Different Retinal Diseases

Case Medical Research, 2020
openaire   +1 more source

Two Doses of Intravitreal Ziv-Aflibercept versus Bevacizumab in Treatment of Diabetic Macular Edema: A Three-Armed, Double-Blind Randomized Trial

Ophthalmology Retina, 2017
Mohammad Hossein Jabbarpoor Bonyadi, Mohsen Azarmina, Siamak Moradian   +2 more
exaly  

One-Year Results of a Trial Comparing 2 Doses of Intravitreal Ziv-aflibercept versus Bevacizumab for Treatment of Diabetic Macular Edema

Ophthalmology Retina, 2018
Mohammad Hossein Jabbarpoor Bonyadi, Mehdi Yasseri, Masoud Soheilian   +2 more
exaly  

Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model

Experimental Eye Research, 2018
Ariel Gore
exaly  

Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture

British Journal of Ophthalmology, 2014
Deepika Malik, M Tarek A Moustafa, M Cristina Kenney   +2 more
exaly  

NCI 8628: A randomized phase 2 study of ziv‐aflibercept and high‐dose interleukin 2 or high‐dose interleukin 2 alone for inoperable stage III or IV melanoma

Cancer, 2018
Ahmad A Tarhini, Paul H Frankel, Hussein A Tawbi   +2 more
exaly